ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
문합기 시장은 2024년부터 2030년까지 예측 기간 동안 CAGR 5.3%로 성장할 것으로 예상됩니다.
문합기 시장은 대장암, 관상동맥질환(CAD) 환자 수 증가, 규제 당국의 승인, 수술 부담 증가 등으로 인해 크게 성장하고 있으며, 예측 기간 동안 성장세가 가속화될 것으로 예상됩니다.
문합기 : 시장 역학
Global Cancer Observatory 2024 자료에 따르면, 2022년 전 세계 대장암 환자 수는 약 192만 6,425명입니다. 이 중 96만 6,399명은 아시아 지역 인구로 전체의 거의 50%를 차지하고, 53만 8,262명은 유럽 인구로 추산됩니다. 전 세계적으로 대장암 발병률이 높아짐에 따라 외과적 치료에 대한 수요가 증가하고 있으며, 문합기는 장 절제 및 재접합에 중요한 역할을 하고 있습니다. 이러한 장치는 수술의 정확성을 높이고 합병증을 줄이며 환자의 결과를 개선하기 때문에 대장암 수술에 필수적인 요소로 자리 잡으며 시장에서의 입지를 강화하고 있습니다.
British Heart Foundation의 Global Heart &Circulatory Diseases Factsheet(2024)에 따르면, 현재 전 세계적으로 약 2억 명이 CAD를 앓고 있습니다. 문합기는 관상동맥 우회술(CABG)과 같은 시술의 정확성과 효율성을 높이고 환자 예후를 개선하며 합병증을 감소시키는 등 CAD 치료에 점점 더 필수적인 요소가 되고 있습니다.
제품별로는 수술용 스테이플러 부문이 2023년 큰 매출 비중을 차지했습니다. 이는 주로 효율적인 혈관 연결을 위한 첨단 수술용 스테이플러 개발에 대한 제조업체의 관심이 증가하고 있으며, 이 부문이 제공하는 다양한 이점이 있기 때문입니다.
외과용 스테이플러는 심혈관 및 소화기 질환 환자에게 빠른 배치, 최소한의 조직 반응, 낮은 감염 위험, 강력한 상처 봉합 등의 이점을 제공합니다. 또한 스테이플러는 다양한 모양과 크기로 제공되어 수술 중 폐쇄 과정을 용이하게 합니다.
세계 문합기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 시장 규모 추정 및 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 문합기 시장 보고서 : 소개
조사 범위
시장 분류
시장 상정
제2장 문합기 시장 : 주요 요약
시장 개요
제3장 경쟁 구도
제4장 규제 분석
미국
유럽
일본
중국
제5장 문합기 시장 : 주요 요인 분석
시장 성장 촉진요인
만성질환 증가
제품 개발 활동 활발화
수술 건수 증가
시장 성장 억제요인과 과제
문합에 의한 합병증
최소침습 치료 접근법 수요 증가
시장 기회
로봇 지원 수술의 도입 확대
생체흡수성 재료 개발
제6장 문합기 시장 : Porter's Five Forces 분석
제7장 문합기 시장 평가
제품별
외과용 스테이플러
외과용 봉합사
외과용 실란트
외과용 접착제
사용성별
일회용
재사용 가능
용도별
심혈관외과
소화기외과
기타
최종사용자별
병원·진료소
외래 수술 센터
지역별
북미
유럽
아시아태평양
기타 지역
제8장 문합기 시장 : 기업·제품 프로파일
B. Braun Melsungen AG
Intuitive Surgical
BAXTER
CryoLife, Inc
Johnson & Johnson Services, Inc.
Medtronic
Sinolinks Medical Innovation, Inc.
microcuremed
BIOWIN PHARMACEUTICAL CO., LIMITED
Waston Medical Corporation
W. L. Gore & Associates, Inc.
Hangzhou Demo Medical Technology Co., Ltd
BD
Dolphin Sutures
gpcmedical
Golden Stapler Surgical Co., Ltd.
JIANGSU JOYMED TECH CO., LTD
Changzhou Haiers Medical Devices Co., Ltd
Shanghai MedEco Industry Co., Ltd
ChangZhou WeiPu Medical Devices CO., LTD
제9장 KOL의 견해
제10장 프로젝트 접근법
제11장 DelveInsight 소개
제12장 면책사항·문의
ksm
영문 목차
영문목차
Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of chronic disorders and the rising product developmental activities worldwide
The anastomosis devices market is projected to grow at a 5.3% CAGR during the forecast period from 2024 to 2030. The anastomosis devices market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease (CAD) among the population, clearances from regulatory bodies, and the growing burden of surgeries are factors that are expected to escalate the overall growth of the anastomosis devices market during the forecast period from 2024 to 2030.
Anastomosis Devices Market Dynamics:
Data from the Global Cancer Observatory 2024, stated that in the year 2022 there were about 1926425 total colorectum cancer cases worldwide. The same source further stated that Asia accounted for 966399 colorectum cancer cases, comprising almost 50% of the total cases, and Europe accounted for 538262 colorectum cancer cases. The high incidence of colorectal cancer globally drives the demand for surgical treatments, where anastomosis devices play a critical role in resecting and reconnecting the colon. These devices enhance surgical precision, reduce complications, and improve patient outcomes, making them indispensable in colorectal cancer surgeries and expanding their market presence.
According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world. Anastomosis devices enhance precision and efficiency in procedures like coronary artery bypass grafting (CABG), improving patient outcomes and reducing complications, making them increasingly integral to CAD treatment.
Increased product development activities by regulatory bodies are also slated to witness market growth for anastomosis devices. For example, in January 2023, Lydus Medical announced that its Vesseal microvascular anastomosis suture deployment system received 510(k) clearance from the US Food and Drug Administration (FDA).
Hence, the interplay of all the above-mentioned factors are expected to drive the market for anastomosis devices market during the given forecast period from 2024 to 2030.
However, complications due to anastomosis, and the increasing demand for minimally invasive or non-invasive treatment approach, among others may restrict the market growth of anastomosis devices.
Anastomosis Devices Market Segment Analysis:
Anastomosis Device Market by Product (Surgical Staplers, Surgical Sutures, Surgical Sealants, and Surgical Adhesives), Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the anastomosis devices market, the surgical staplers category is expected to have a significant revenue share in the year 2023. This is primarily owing to the rising focus of manufacturers toward developing technologically advanced surgical staplers for an improved and efficient connection of vessels and the other various advantages offered by the category.
The surgical staplers provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The staplers are also available in different shapes and sizes, easing the process of closure during surgery.
Further, the increasing product launches and regulatory approvals of the anastomosis devices will aid in increasing its demand in the market. For instance, in March 2021, FDA approved Viola clamps, a less proximal anastomosis device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).
Therefore, owing to the aforementioned factors, the surgical staplers category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomosis device market during the forecast period.
North America is expected to dominate the overall anastomosis devices market:
Among all the regions, North America is estimated to hold a significant revenue share in the anastomosis devices market. This can be attributed to several factors such as rising colorectum cancer cases, the presence of key market players, combined with significant advancements in product development and regulatory approvals that are acting as key factors contributing to the growth of the anastomosis devices market in the North America region during the forecast period from 2024 to 2030.
According to data from the Global Cancer Observatory 2024, it stated that in the year 2022, there were 183911 total colorectum cancer cases in the region. The same source further stated that the US accounted for 160186 colorectum cancer cases which is almost 87% of the total cases, and Canada accounted for 23725 colorectum cancer cases. Anastomosis devices are essential for reconnecting bowel segments during surgical resections. Advanced devices improve surgical precision, reduce complications, and enhance recovery, making them indispensable in managing colorectal cancer cases and expanding their market.
Additionally, in October 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration cleared GT Metabolic's MagDI(TM) System for side-to-side duodeno-ileal (DI) anastomosis.
The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional anastomosis devices market growth. The presence of key players such as Johnson & Johnson Services, Inc., B.Braun Melsungen AG, and Medtronic with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.
Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the anastomosis devices market during the forecast period from 2024 to 2030.
Anastomosis Devices Market key players:
Some the key market players operating in the anastomosis devices market include B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.
Recent Developmental Activities in the Anastomosis Devices Market:
In April 2021, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.
In March 2021, Johnson & Johnson launched the ECHELON Stapler, which is a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.
In February 2021, Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for VIOLA. This is a new device for clampless proximal anastomosis in CABG.
Key takeaways from the Anastomosis Devices market report study
Market size analysis for current anastomosis devices market size (2023), and market forecast for 6 years (2024 to 2030)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the anastomosis devices market
Various opportunities available for other competitors in the anastomosis devices market space
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current anastomosis devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for anastomosis devices market growth in the coming future?
Target audience who can be benefited from this Anastomosis Devices market report study
Anastomosis device providers
Research organizations and consulting companies
Anastomosis devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in anastomosis devices
Various end-users who want to know more about the anastomosis devices market and the latest developments in the anastomosis devices market
Frequently Asked Questions for the Anastomosis Devices Market:
1. What are anastomosis devices?
The anastomosis device is used for making the surgical connection between two tubular structures, such as blood vessels or loops of the intestine. An anastomosis is a surgical procedure that involves connecting two structures and is performed after the resection of an organ to connect the remaining sections.
2. What is the market for anastomosis devices?
The anastomosis devices market is projected to grow at a 5.3% CAGR during the forecast period from 2024 to 2030.
3. What are the drivers for the anastomosis devices market?
The anastomosis devices market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease among the population, clearances from regulatory bodies, and the growing burden of surgeries are factors that are expected to escalate the overall growth of the anastomosis devices market during the forecast period from 2024 to 2030.
4. Who are the key players operating in the anastomosis devices market?
Some of the major market players operating in the anastomosis devices market include B. Braun Melsungen AG, Intuitive Surgical, BAXTER, CryoLife, Inc, Johnson & Johnson Services, Inc., Medtronic, Sinolinks Medical Innovation, Inc., microcuremed, BIOWIN PHARMACEUTICAL CO., LIMITED, Waston Medical Corporation, W. L. Gore & Associates, Inc., Hangzhou Demo Medical Technology Co., Ltd, BD, Dolphin Sutures, gpcmedical, Golden Stapler Surgical Co., Ltd., JIANGSU JOYMED TECH CO., LTD, Changzhou Haiers Medical Devices Co., Ltd, Shanghai MedEco Industry Co., Ltd, ChangZhou WeiPu Medical Devices CO., LTD, and others.
5. Which region has the highest share in the anastomosis devices market?
Among all the regions, North America is estimated to hold a significant revenue share in the anastomosis devices market. This can be attributed to several factors such as the rising colorectum cancer cases, the presence of key market players, combined with significant advancements in product development and regulatory approvals are acting as key factors that contribute to the growth of the anastomosis devices market in the North America region during the forecast period from 2024 to 2030.
